Bayesian Capital Management’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,600
Closed -$70.2K 784
2023
Q3
$70.2K Buy
14,600
+700
+5% +$3.55K 0.01% 627
2023
Q2
$84.7K Buy
+13,900
New +$64.7K 0.01% 700
2023
Q1
Sell
-19,479
Closed -$60.6K 818
2022
Q4
$60.6K Buy
19,479
+9,048
+87% +$26.6K 0.01% 693
2022
Q3
$42K Buy
+10,431
New +$49.5K 0.01% 630
2021
Q4
Sell
-12,096
Closed -$249K 396
2021
Q3
$249K Buy
+12,096
New +$309K 0.07% 306

Other funds holding CGNT

Bayesian Capital Management's CGNT Position: Q4 2023 in Review

Bayesian Capital Management sold out of Cognyte Software (CGNT) in Q4 2023, closing a stake of 14,600 shares — an estimated $70.2K sold.

Bayesian Capital Management first reported a position in CGNT in Q3 2021 and held it in 5 quarters. The position peaked at $249K in Q3 2021. 112 funds tracked by Wall St. Rank hold CGNT as of Q4 2023.

  • Bayesian Capital Management reported no remaining Cognyte Software position as of Q4 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 14,600 Cognyte Software shares in Q4 2023, an estimated $70.2K.
  • Bayesian Capital Management first reported a position in Cognyte Software in Q3 2021 and held it in 5 quarters.
  • Bayesian Capital Management's Cognyte Software position peaked at $249K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Cognyte Software as of Q4 2023.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.